Morepen Laboratories P/B Ratio
Morepen Laboratories (MOREPENLAB) P/B ratio is 4.67 (High), book value per share ₹113.36 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore MOREPENLAB investment value to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
MOREPENLAB P/B Ratio — Valuation Insights & Book Value Analysis
Morepen Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 4.67 (High). For live price, earnings yield and the full fundamental profile, see MOREPENLAB stock price BSE.
- Stock appears overvalued with PB of 4.67, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 534.5% above historical average
- Trading at premium to sector average PB of -0.01
Morepen Laboratories P/B Ratio Historical Trend
MOREPENLAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read MOREPENLAB ex-dividend dates for the complete payout history and dividend yield track record.
MOREPENLAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Morepen Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.07 | ₹113.36 | ₹120.90 | ₹1,247 | Moderate |
| 2025 | 0.38 | ₹107.91 | ₹41.07 | ₹1,187 | Low |
| 2024 | 0.94 | ₹83.04 | ₹78.16 | ₹847 | Low |
| 2023 | 0.66 | ₹73.73 | ₹48.55 | ₹752 | Low |
| 2022 | 0.63 | ₹60.21 | ₹37.85 | ₹578 | Low |
MOREPENLAB vs Healthcare Peers — P/B Ratio Comparison
Morepen Laboratories P/B 4.67 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |